Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2016 by Pluristem Ltd.
Sponsor:
Information provided by (Responsible Party):
Pluristem Ltd.
ClinicalTrials.gov Identifier:
NCT01679990
First received: September 2, 2012
Last updated: November 23, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: July 2017 (Final data collection date for primary outcome measure)